Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Completed 4Unknown 2Terminated 1Not yet recruiting 1Enrolling by invitation 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 1Breast 1

Conditions

Glioma 1Cognitive Dysfunction 1Cognition Disorders 1Chemotherapy-Related Cognitive Impairment 1Breast Neoplasms 1Brain Neoplasms 1

Interventions

Cisplatin 512Radiotherapy 376Cyclophosphamide 361Carboplatin 354Capecitabine 341Oxaliplatin 331Paclitaxel 328Gemcitabine 318Docetaxel 314Fluorouracil 288Drug Therapy 271apatinib 245Bevacizumab 243camrelizumab 217Etoposide 200Irinotecan 182Doxorubicin 180Leucovorin 160Dexamethasone 160pembrolizumab 150sintilimab 143Neoadjuvant Therapy 142anlotinib 139Pemetrexed 138Cytarabine 138Blood Specimen Collection 138Surgical Procedures, Operative 130toripalimab 128Radiosurgery 127S 1 (combination) 124

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Cognitive Training × Clear all
NCT06103318 2024-03-06

ICOgnition

Institut Català d'Oncologia

Phase NA Unknown
176 enrolled
Breast

Chemotherapy-Related Cognitive Impairment, Breast Neoplasms, Cognitive Dysfunction

NCT00256425 2008-03-21

Cognitive Rehabilitation of Glioma Patients

UMC Utrecht

Phase 3 Unknown
140 enrolled
CNS

Brain Neoplasms, Cognition Disorders, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡